Mohammed Alkattan
Product Development Director @Gentell
Signup · Get unlimited contacts
WORK HISTORY
Product Development Director @Gentell
As Director of Product Development at Gentell, I lead the end-to-end innovation lifecycle for advanced wound care products—from early-stage concept to regulatory submission and commercial launch. I oversee cross-functional teams in Business, R&D, formulation, prototyping, pre-clinical studies, clinical validation, and regulatory alignment, ensuring all product development aligns with international standards and patient-centred outcomes.Key areas of focus:1- Driving the development of next-generation hydrogel technologies, biofilm-inhibiting platforms, and combination devices2- Leading design control, risk management (ISO 14971), and biological safety strategies (ISO 10993) under EU MDR, FDA, UK MDR, and MDSAP frameworks3- Collaborating with clinicians, engineers, regulatory experts, and commercial teams to transform insights into differentiated, scalable solutions4-Reducing time-to-market and development risk through agile project management, feasibility testing, and robust design validation5- Building partnerships with biotech and material science innovators to bring novel technologies into the wound care pipeline
EDUCATION
University of Glasgow
Doctor of Philosophy (PhD), Monomer, catalyst and Organic Synthesis
Newcastle University
Master's Degree, Organic Chemistry and Drug Synthesis
Damascus University
Bachelor of Applied Science - BASc, Chemistry
Saïd Business School, University of Oxford
Venture Creation & Finance, Entrepreneurship/Entrepreneurial Studies
Oxford Brookes University
Course, Business Administration, Management and Operations
The University of Edinburgh
Doctor of Philosophy (Ph.D.), Polymer Chemistry
SKILLS
ABOUT MOHAMMED ALKATTAN
I help medical device, biomaterials, and drug-delivery companies translate complex technologies into regulatory-approved, commercially scalable products.My work sits at the intersection of advanced biomaterials, medical device development, and regulatory strategy. Over the past 17+ years, I have led programmes bringing polymer and hydrogel technologies from early concept through regulatory approval and market launch across EU, UK, US and global markets.My experience spans Class medical devices, implantable technologies, and drug-device combination products, particularly where materials science, regulatory requirements, and manufacturing readiness must be aligned early in development.I focus on aligning technology development, regulatory strategy, and product delivery to ensure complex medical technologies progress efficiently from innovation to market.My experience includes:• EU MDR and FDA regulatory strategy• Design History Files (DHF) and Technical Documentation• Risk Management (ISO 14971) and Clinical Evaluation• Biomaterials and polymer-based medical devices• Combination products and drug-delivery technologies• Biocompatibility strategy (ISO 10993)• GMP manufacturing scale-up and technology transfer• Product commercialisation and global market entryI have worked across medical devices, drug delivery, biomaterials, and wound care, supporting organisations in navigating regulatory complexity while accelerating development timelines.In addition to industry roles, I deliver training and advisory support to global companies on biomaterials, polymer medical devices, and regulatory frameworks.If you are developing advanced medical technologies and need technical-regulatory leadership, I would be glad to connect.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.